Table 2: Feasibility of FLT-PET imaging in patients with PDAC.
|
Total of scans acquired (N=35) |
Total |
Evaluable |
Evaluable (%) |
|
|
Evaluable scans |
Total |
35 |
31* |
89 |
|
Baseline san |
18 |
17 |
94 |
|
|
Repeatability scan |
5 |
4 |
80 |
|
|
Response scan |
12 |
10 |
83 |
|
|
Patients |
Total |
18 |
12# |
67 |
A total of 35 scans were performed, of which *4 scans (11%) were not evaluable due to protocol violation (n=1), FLT tissue extravasation at scan start (n=1), patient movement during scan (n=2); #Of the 18 patients who had a baseline scan, 6 (33%) patients did not have a repeat scan, due to inability to have a second scan (n=3, due to poor PS at time of repeatability/response scan), chemotherapy never started (n=1), repeatability scan not evaluable due to patient’ movement (n=1), and response scan not evaluable due to protocol violation (n=1; administration of cycle 2 day 1 of chemotherapy before response scan).